Clinical case of SARS-CoV-2 infection in a patient with rheumatoid arthritis and secondary AA-amyloidosis of the lungs
https://doi.org/10.14412/1996-7012-2023-1-89-92
Abstract
In rheumatic diseases, the risk of infections development is higher than in the general population. The article describes a case of SARS-CoV-2 infection in a patient with rheumatoid arthritis (RA) and secondary AA-amyloidosis of the lungs, which led to a fatal outcome. In the context of the COVID-19 pandemic, RA patients with secondary AA-amyloidosis and pulmonary fibrosis are likely to represent a special risk group for developing a severe course of this infection with a fatal outcome.
About the Authors
O. V. Vorobeva
Chuvash State University named after I.N. Ulyanov
Russian Federation
Russian Federation
Olga Vasilievna Vorobeva
15, Moskovsky Рrospect, Cheboksary 428015, Russia
L. P. Romanova
Chuvash State University named after I.N. Ulyanov
Russian Federation
Russian Federation
15, Moskovsky Рrospect, Cheboksary 428015, Russia
References
1. Nasonov EL. Coronavirus disease 2019 (COVID-19): reflections from a rheumatologist. Nauchno-prakticheskaya revmatologiya. 2020;58(2):123-32. (In Russ.).
2. Sarkisova IA, Rameev VV, Varshavskii VA. Features of AA-amyloidosis in patients with rheumatoid arthritis. Terapevticheskii arkhiv. 2006;(5):32-5. (In Russ.).
3. Murav'ev YuV, Alekseeva AV. The frequency of AA-amyloidosis in rheumatic diseases (according to the data of the Institute of Rheumatology of the Russian Academy of Medical Sciences). Nauchno-prakticheskaya revmatologiya. 2004;42(3):20-2. (In Russ.).
4. Gomzikova EA, Samsonova MV, Chernyaev AL, Kurkov AV. Amyloidosis of the lungs: the basis of diagnosis. Prakticheskaya pul'monologiya. 2017;(3):90-7. (In Russ.).
5. Tret'yakov AYu, Zakharchenko SP, Tret'yakova VA. Pulmonary amyloidosis. Pul'monologiya. 2018;28(1):75–83. (In Russ.). doi: 10.18093/0869-0189-2018-28-1-75-83.
6. Vorob'eva OV, Lastochkin AV, Gimaldinova NE. Clinical and morphological characteristic case of system al-amyloidosis. Sovremennye problemy nauki i obrazovaniya. 2020;(3):151. (In Russ.). doi: 10.17513/spno.29795.
7. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28; 395(10229):1054-62. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8. Vorob'eva OV, Lastochkin AV. Changes in the brain, lungs and heart with COVID-19 against the background of cerebrovascular pathology. Profilakticheskaya meditsina. 2020;23(7):43-6. (In Russ.).
Review
For citations:
Vorobeva OV, Romanova LP. Clinical case of SARS-CoV-2 infection in a patient with rheumatoid arthritis and secondary AA-amyloidosis of the lungs. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2023;17(1):89–92. (In Russ.) https://doi.org/10.14412/1996-7012-2023-1-89-92
Views:
511
Email this article 